In 1999, 18-year-old Jesse Gelsinger eagerly signed up for a clinical trial testing a promising therapy for his rare genetic disorder. The Arizona resident’s dream was to lead a normal life that wouldn’t require him swallowing four dozen pills a day simply to stay alive.He traveled to the University...
